Get the Stockscreener App
5.16
5.52%
0.27
After Hours:
5.16
Quanterix Corp stock is traded at $5.16, with a volume of 676.17K.
It is up +5.52% in the last 24 hours and down -28.53% over the past month.
Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.
See More
Previous Close:
$4.89
Open:
$5
24h Volume:
676.17K
Relative Volume:
0.88
Market Cap:
$207.91M
Revenue:
$121.14M
Net Income/Loss:
$-32.33M
P/E Ratio:
-6.00
EPS:
-0.86
Net Cash Flow:
$-22.69M
1W Performance:
-3.73%
1M Performance:
-28.53%
6M Performance:
-58.79%
1Y Performance:
-68.34%
1-Day Range:
$4.97
$5.21
1-Week Range:
$4.815
$5.46
52-Week Range:
$4.67
$19.18
Quanterix Corp Stock (QTRX) Company Profile
Name
Quanterix Corp
Sector
Industry
Phone
617-301-9400
Address
900 MIDDLESEX TURNPIKE, BILLERICA, MA
Compare QTRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
QTRX
Quanterix Corp
|
5.16 | 207.91M | 121.14M | -32.33M | -22.69M | -0.86 |
|
ABT
Abbott Laboratories
|
131.73 | 218.91B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
95.05 | 139.37B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
348.12 | 134.90B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
83.37 | 106.90B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
70.60 | 41.45B | 5.72B | 4.17B | 259.90M | 6.97 |
Quanterix Corp Stock (QTRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-01-24 | Initiated | Scotiabank | Sector Outperform |
| Sep-25-23 | Upgrade | Canaccord Genuity | Hold → Buy |
| Aug-08-23 | Upgrade | SVB Securities | Market Perform → Outperform |
| May-23-23 | Upgrade | Goldman | Neutral → Buy |
| Aug-15-22 | Downgrade | Canaccord Genuity | Buy → Hold |
| Aug-09-22 | Downgrade | Cowen | Outperform → Market Perform |
| Aug-09-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Mar-02-22 | Upgrade | Goldman | Sell → Neutral |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Jun-04-21 | Initiated | Goldman | Sell |
View All
Quanterix Corp Stock (QTRX) Latest News
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RKDA, CKPT, QTRX on Behalf of Shareholders - marketscreener.com
QUANTERIX CORP : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Change in Directors or Principal Officers (form 8-K) - marketscreener.com
Kent Lake Files Definitive Proxy Statement And Sends Letter To Quanterix Shareholders - marketscreener.com
Kent Lake Files Definitive Proxy Statement and Sends Letter to Quanterix Shareholders - marketscreener.com
Quanterix Co. (NASDAQ:QTRX) Shares Purchased by Vanguard Group Inc. - Defense World
Tikvah Management Calls on Quanterix to Explain the Egregious Te - GuruFocus
Tikvah Management Calls on Quanterix to Explain the Egregious Terms of Convertible Notes Purchased from Akoya Biosciences - Bluefield Daily Telegraph
Quanterix Faces Investor Backlash: $30M Convertible Notes Deal Under Fire - Stock Titan
American Century Companies Inc. Grows Stock Position in Quanterix Co. (NASDAQ:QTRX) - Defense World
KLP Kapitalforvaltning AS Takes $66,000 Position in Quanterix Co. (NASDAQ:QTRX) - Defense World
53,626 Shares in Quanterix Co. (NASDAQ:QTRX) Acquired by Raymond James Financial Inc. - MarketBeat
Quanterix stock plunges to 52-week low of $4.85 amid market challenges - Investing.com
Raymond James Financial Inc. Purchases New Position in Quanterix Co. (NASDAQ:QTRX) - Defense World
Kent Lake Comments on Quanterix?s Bridge Financing for Akoya - MarketScreener
Quanterix Under Fire: Top Investor Warns of 'Value Destructive' $30M Deal with Struggling Akoya - Stock Titan
$TOCKHOLDER ALERT: The M&A Class Action Firm Urges Shareholders of FNA, BECN, QTRX, PLYA to Take Action - GlobeNewswire Inc.
Quanterix: Still Many, Many Questions - Seeking Alpha
Quanterix Showcases Innovation Powered by Simoa® at AD/PD with Customer Research and New Dried Blood Spot Extraction Kit - Yahoo Finance
Revolutionary Blood Spot Kit Makes Alzheimer's Testing More Accessible and Affordable - Stock Titan
Quanterix Co. (NASDAQ:QTRX) Sees Large Decline in Short Interest - MarketBeat
Quanterix stock plunges to 52-week low at $6.27 amid market challenges - Investing.com
Quanterix CorpOn March 24, Appointed William P. Donnelly As ChairmanSEC Filing - MarketScreener
Charles Schwab Investment Management Inc. Sells 58,989 Shares of Quanterix Co. (NASDAQ:QTRX) - Defense World
Scotiabank cuts Quanterix stock price target to $18 from $28 By Investing.com - Investing.com Australia
Quanterix (NASDAQ:QTRX) Given New $18.00 Price Target at Scotiabank - Defense World
Scotiabank cuts Quanterix stock price target to $18 from $28 - Investing.com India
Bank of New York Mellon Corp Has $1.15 Million Stake in Quanterix Co. (NASDAQ:QTRX) - Defense World
Tikvah to oppose Quanterix-Akoya Biosciences merger By Investing.com - Investing.com Australia
Tikvah to oppose Quanterix-Akoya Biosciences merger - Investing.com India
Tikvah Management Announces Intention to Vote AGAINST Quanterix’s Proposed Merger with Akoya Biosciences - Business Wire
Connor Clark & Lunn Investment Management Ltd. Cuts Holdings in Quanterix Co. (NASDAQ:QTRX) - Defense World
Key Investor Fights Back: Quanterix Merger Under Fire Over Valuation Concerns - Stock Titan
What is Leerink Partnrs’ Estimate for Quanterix Q1 Earnings? - Defense World
Quanterix Corporation (NASDAQ:QTRX) Q4 2024 Earnings Call Transcript - Insider Monkey
Quanterix Full Year 2024 Earnings: EPS Misses Expectations - Yahoo Finance
Quanterix (NASDAQ:QTRX) Price Target Cut to $15.00 by Analysts at Canaccord Genuity Group - Defense World
Canaccord cuts Quanterix stock target to $15, maintains Buy rating By Investing.com - Investing.com Australia
Quanterix stock plunges to 52-week low of $6.66 amid market challenges - Investing.com
Canaccord cuts Quanterix stock target to $15, maintains Buy rating - Investing.com India
Quanterix Corp (QTRX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid Market Challenges - Yahoo
Earnings call transcript: Quanterix Q4 2024 misses EPS forecast, stock rises - Investing.com Canada
Earnings call transcript: Quanterix Q4 2024 misses EPS forecast, stock rises By Investing.com - Investing.com South Africa
Quanterix Corp reports results for the quarter ended December 31Earnings Summary - TradingView
Quanterix sees FY25 revenue $140M-$146M, consensus $154.7M - TipRanks
Quanterix Corp SEC 10-K Report - TradingView
Kent Lake urges Quanterix to address questions regarding Akoya deal -March 17, 2025 at 04:28 pm EDT - Marketscreener.com
Quanterix Corporation Reports Seventh Consecutive Quarter of Double-Digit Revenue Growth - TradingView
Quanterix earnings missed by $0.07, revenue fell short of estimates - Investing.com
QUANTERIX Earnings Preview: Recent $QTRX Insider Trading, Hedge Fund Activity, and More - Nasdaq
Quanterix Q4 2024 Earnings: Key Financial Results Coming March 17How to Listen Live - Stock Titan
Quanterix Corp (NASDAQ: QTRX) Is Down -1.62% – Is It Capable Of A Rally? - Stocks Register
Quanterix Corp Stock (QTRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.32%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):